BofA raises Merck stock price target to $141 on cancer drug potential

BofA raises Merck stock price target to $141 on cancer drug potential  Investing.com Nigeria

Summary aggregated from Investing.com Nigeria's public RSS feed. The full reporting belongs to Investing.com Nigeria — please read it on their site.